| |
|
Examination and
Assessment of a Suspected DVT |
|
|
Sarah Munroe, Anticoagulation
Sister, Luton Treatment Centre(LTC)
|
Here in outline is how we organize and manage
our specialist and dedicated DVT Treatment Centre.
-
A Nurse led service
-
Operates between 9am to 19pm Monday to
Friday
-
On call Nurse designated on weekends to
administer subcutaneous tinzaparin (LMWH) injections
-
We only handle Luton Primary Care Trust(PCT)
General Practitioner ( GP) referrals.
-
Clinical responsibility remains with the GP
until a DVT is confirmed
-
Patient is seen the same day as referred by
GP
-
Patient must present with a GP referral
letter detailing past and present medical history and a
current medication list
-
The patient’s suitability for the community
pathway must be assessed by the GP prior to referral using
the criteria assessment form
-
If the DVT Nurse deems the patient
unsuitable at any point on presentation to the LTC they
will be immediately directed to the Luton and Dunstable
NHS Trust hospital Haematology Dept.(Secondary care)
-
Baseline observations are performed on
arrival to LTC
-
The patient is assessed using the clinical
scoring form
-
If there is a low clinical score (less than
2) a venous blood sample is obtained and a D-Dimer test is
performed, if the test is below 450ng/ml the D-Dimer test
is negative and the patient is referred back to their GP
for follow up
-
If the D-Dimer result is above 450ng/ml the
D-Dimer test is positive subcutaneous LMWH is commenced
and a Doppler scan is arranged. FBC, U&E, LFT and INR
blood tests are sent to the path lab
-
If the Clinical score is high (2 or above)
Subcutaneous LMWH is commenced and a Doppler scan is
arranged. FBC, U&E, LFT and INR blood tests are sent to
the path lab
-
If the Doppler scan which is performed at
the hospital is negative to DVT the patient is discharged
back to their GP from the ultrasound department
-
If the Doppler scan is positive to DVT the
patient is sent to the anticoagulant clinic also in the
hospital to commence warfarin tablets and remain on
subcutaneous LMWH until INR therapeutic.
|
Back |
|
|
|
|
|